All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
LONDON - Stem cell innovation in the UK is at risk because of structural and cultural barriers that stand in the way of translating products into clinical use. (BioWorld International)
